marketcaparena
Search

    SUPN

    SUPERNUS PHARMACEUTICALS, INC.

    Company overview

    Market capitalization
    $2.59B
    Employees
    778
    Latest publication
    2026-09-29
    About SUPERNUS PHARMACEUTICALS, INC.

    Supernus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. It offers Qelbree, a non-stimulant indicated for the treatment of attention-deficit hyperactivity disorder (ADHD); GOCOVRI for the treatment of dyskinesia and levodopa/carbidopa in patients with Parkinson's Disease (PD); Oxtellar XR, an extended-release oxcarbazepine product indicated for the monotherapy treatment of partial onset epilepsy seizures; and APOKYN for the acute and intermittent treatment of hypomobility or off episodes in patients with advanced PD. It also provides Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; XADAGO for the treatment of levodopa/carbidopa in patients with PD experiencing off episodes; and MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and chronic sialorrhea. In addition, the company develops ONAPGO, which received FDA approval, for the treatment of motor fluctuations in adults with advanced PD; SPN-817, a first-in-class selective acetylcholinesterase inhibitor, which is in Phase 2 clinical trial, for the treatment of epilepsy, partial seizures, Dravet syndrome, and Lennox-Gaustaut syndrome; SPN-820, a small molecule in Phase 2 clinical trial for treating resistant depression; and SPN-443, a stimulant in Phase 1 trial for the treatment of ADHD/CNS. It markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. It has a development agreement with Navitor Inc. for the conduct of Phase 2 clinical program of SPN-820. Supernus Pharmaceuticals, Inc. was incorporated in 2005 and is based in Rockville, Maryland.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20252025-12-31 · USDQ2 20252025-06-30 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ4 20232023-12-31 · USDQ3 20232023-09-30 · USD
    Total Revenue219,058,000USD211,572,000USD165,453,000USD174,159,000USD175,689,000USD168,325,000USD164,314,000USD153,880,000USD
    Cost Of Revenue33,669,000USD23,007,000USD16,827,000USD26,098,000USD17,583,000USD17,916,000USD19,627,000USD19,601,000USD
    Gross Profit185,389,000USD188,565,000USD148,626,000USD148,061,000USD158,106,000USD150,409,000USD144,687,000USD134,279,000USD
    Research Development29,463,000USD27,827,000USD22,115,000USD28,647,000USD29,036,000USD26,183,000USD23,347,000USD22,655,000USD
    Selling General Administrative133,637,000USD39,205,000USD28,421,000USD24,816,000USD15,424,000USD27,100,000USD26,005,000USD25,915,000USD
    Other Operating Expenses25,333,000USD———————
    Total Operating Expenses243,352,000USD174,743,000USD136,485,000USD126,656,000USD117,261,000USD127,840,000USD145,683,000USD126,141,000USD
    Operating Income-57,963,000USD13,822,000USD12,141,000USD21,405,000USD40,845,000USD22,569,000USD-996,000USD8,138,000USD
    Total Other Income Expense Net315,000USD-15,736,000USD4,528,000USD4,977,000USD4,098,000USD3,733,000USD1,986,000USD1,751,000USD
    Interest Expense2,315,000USD——0USD0USD0USD4,830,000USD0USD
    Income Before Tax-57,648,000USD-1,914,000USD16,669,000USD26,382,000USD44,943,000USD26,302,000USD990,000USD9,889,000USD
    Income Tax Expense723,000USD2,191,000USD-5,830,000USD11,054,000USD6,446,000USD6,386,000USD-185,000USD25,865,000USD
    Net Income-58,371,000USD-4,105,000USD22,499,000USD15,328,000USD38,497,000USD19,916,000USD1,175,000USD-15,976,000USD
    Selling And Marketing Expenses—83,185,000USD65,130,000USD54,593,000USD54,329,000USD58,804,000USD55,277,000USD56,785,000USD
    Unclassified Operating Expenses—24,526,000USD20,819,000USD18,600,000USD18,472,000USD15,753,000USD41,054,000USD20,786,000USD
    Interest Income—2,023,000USD4,528,000USD4,977,000USD4,098,000USD3,733,000USD1,986,000USD1,751,000USD
    Net Interest Income—2,023,000USD4,528,000USD4,977,000USD4,098,000USD3,733,000USD1,986,000USD1,751,000USD
    Tax Provision—2,191,000USD-5,830,000USD11,054,000USD6,446,000USD6,386,000USD-185,000USD25,865,000USD
    Net Income From Continuing Ops—-4,105,000USD22,499,000USD15,328,000USD38,497,000USD19,916,000USD1,175,000USD-15,976,000USD
    Ebit—1,656,000USD16,669,000USD26,382,000USD44,943,000USD18,214,000USD990,000USD9,889,000USD
    Ebitda—26,672,000USD38,027,000USD45,227,000USD65,045,000USD38,932,000USD22,666,000USD31,746,000USD
    Depreciation And Amortization—25,016,000USD21,358,000USD18,845,000USD20,102,000USD20,718,000USD21,676,000USD21,857,000USD
    Reconciled Depreciation—25,016,000USD21,358,000USD18,845,000USD20,102,000USD20,718,000USD21,676,000USD21,857,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
    Total Revenue661,817,000USD607,521,000USD667,238,000USD579,775,000USD520,397,000USD392,755,000USD408,897,000USD302,238,000USD
    Cost Of Revenue77,906,000USD83,779,000USD87,221,000USD75,061,000USD52,459,000USD16,660,000USD15,356,000USD15,215,000USD
    Gross Profit583,911,000USD523,742,000USD580,017,000USD504,714,000USD467,938,000USD376,095,000USD393,541,000USD287,023,000USD
    Research Development108,796,000USD91,593,000USD74,552,000USD90,467,000USD75,961,000USD69,099,000USD89,209,000USD49,577,000USD
    Selling General Administrative247,282,000USD236,661,000USD109,433,000USD105,050,000USD65,924,000USD117,625,000USD116,588,000USD104,105,000USD
    Selling And Marketing Expenses88,500,000USD99,700,000USD267,788,000USD199,709,000USD134,753,000USD40,800,000USD43,300,000USD33,800,000USD
    Unclassified Operating Expenses57,667,000USD101,057,000USD82,120,000USD23,459,000USD17,602,000USD———
    Total Operating Expenses502,245,000USD529,011,000USD533,893,000USD418,685,000USD294,240,000USD227,524,000USD249,097,000USD187,482,000USD
    Operating Income81,666,000USD-5,269,000USD46,124,000USD86,029,000USD173,698,000USD148,571,000USD144,444,000USD99,541,000USD
    Interest Income16,204,000USD10,867,000USD21,689,000USD10,569,000USD18,704,000USD21,623,000USD13,843,000USD2,864,000USD
    Interest Expense0USD2,415,000USD7,070,000USD23,423,000USD23,754,000USD22,707,000USD18,111,000USD1,568,000USD
    Net Interest Income16,204,000USD6,858,000USD14,619,000USD-12,854,000USD-5,050,000USD-1,084,000USD-4,268,000USD1,296,000USD
    Income Before Tax97,870,000USD2,769,000USD60,743,000USD73,175,000USD168,648,000USD147,487,000USD140,176,000USD100,618,000USD
    Income Tax Expense24,005,000USD1,453,000USD32,000USD19,751,000USD41,698,000USD34,431,000USD29,183,000USD43,334,000USD
    Tax Provision24,005,000USD11,297,000USD32,000USD19,751,000USD41,698,000USD34,431,000USD29,183,000USD43,334,000USD
    Net Income73,865,000USD1,316,000USD60,711,000USD53,424,000USD126,950,000USD113,056,000USD110,993,000USD57,284,000USD
    Net Income From Continuing Ops73,865,000USD25,622,000USD60,711,000USD53,424,000USD126,950,000USD113,056,000USD110,993,000USD57,284,000USD
    Ebit97,870,000USD5,184,000USD67,813,000USD96,598,000USD192,402,000USD170,194,000USD144,444,000USD99,541,000USD
    Ebitda178,284,000USD90,043,000USD153,356,000USD129,193,000USD210,543,000USD180,419,000USD151,507,000USD107,673,000USD
    Depreciation And Amortization80,414,000USD84,859,000USD85,543,000USD32,595,000USD18,141,000USD10,225,000USD7,063,000USD8,132,000USD
    Reconciled Depreciation80,414,000USD84,032,000USD82,630,000USD32,595,000USD18,141,000USD6,659,000USD7,063,000USD8,132,000USD
    Total Other Income Expense Net16,204,000USD8,038,000USD14,619,000USD-12,854,000USD-5,050,000USD-1,084,000USD-4,268,000USD1,077,000USD
    Non Operating Income Net Other——14,619,000USD-12,854,000USD-5,050,000USD-1,084,000USD9,572,000USD1,211,000USD
    Net Income Applicable To Common Shares——60,711,000USD53,424,000USD126,950,000USD113,056,000USD110,993,000USD57,284,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,428,109,000USD1,500,725,000USD1,452,648,000USD1,419,754,000USD1,382,405,000USD1,347,290,000USD1,368,073,000USD1,342,701,000USD
    Cash And Equivalents179,953,000USD———————
    Total Current Assets723,496,000USD731,580,000USD644,182,000USD593,891,000USD738,866,000USD687,584,000USD686,070,000USD640,003,000USD
    Other Current Assets55,849,000USD78,094,000USD65,325,000USD62,078,000USD31,416,000USD28,931,000USD36,088,000USD27,404,000USD
    Other Non Current Assets55,015,000USD———————
    Total Liabilities396,883,000USD———————
    Total Current Liabilities347,378,000USD373,929,000USD338,171,000USD330,629,000USD286,360,000USD281,772,000USD292,397,000USD291,508,000USD
    Other Current Liabilities40,076,000USD———————
    Other Non Current Liabilities19,872,000USD———————
    Total Stockholder Equity1,031,226,000USD1,076,805,000USD1,061,714,000USD1,049,666,999USD1,063,900,000USD1,030,705,000USD1,035,733,000USD1,007,150,000USD
    Total Equity Including Noncontrolling Interest1,031,226,000USD———————
    Net Receivables211,656,000USD182,183,000USD187,802,000USD171,254,000USD140,831,000USD145,640,000USD142,077,000USD145,408,000USD
    Property Plant Equipment Net10,197,000USD36,439,000USD10,531,000USD10,627,000USD11,069,000USD11,338,000USD11,545,000USD11,876,000USD
    Goodwill119,431,000USD———————
    Intangible Assets469,459,000USD549,712,000USD569,456,000USD623,481,000USD481,307,000USD502,126,000USD521,912,000USD540,156,000USD
    Accounts Payable108,458,000USD10,171,000USD2,677,000USD8,177,000USD8,215,000USD7,072,000USD4,587,000USD6,392,000USD
    Common Stock58,000USD58,000USD57,000USD57,000USD56,000USD56,000USD56,000USD55,000USD
    Retained Earnings457,212,000USD515,582,999USD517,876,000USD521,981,000USD567,098,000USD544,599,000USD556,426,000USD541,098,000USD
    Accumulated Other Comprehensive Income-138,000USD-255,000USD-44,000USD-71,000USD-200,000USD-159,000USD-189,000USD78,000USD
    Total Liab—423,920,000USD390,934,000USD370,087,000USD318,505,000USD316,585,000USD332,340,000USD335,551,000USD
    Other Current Liab—353,122,000USD324,882,000USD311,662,000USD270,754,000USD268,763,000USD280,921,000USD275,889,000USD
    Capital Stock—58,000USD57,000USD57,000USD56,000USD56,000USD56,000USD55,000USD
    Good Will—120,668,000USD124,882,000USD119,080,000USD117,019,000USD117,019,000USD117,019,000USD117,019,000USD
    Other Assets—1USD————-132,734,000USD—
    Cash—184,869,000USD128,448,000USD151,371,000USD144,711,000USD115,848,000USD69,331,000USD31,673,000USD
    Cash And Short Term Investments—384,241,000USD308,670,000USD281,160,000USD522,596,000USD463,590,000USD453,612,000USD403,210,000USD
    Net Debt—-143,966,000USD-87,471,000USD-109,159,000USD-112,937,000USD-83,543,000USD-35,060,000USD6,480,000USD
    Short Term Debt—10,636,000USD10,612,000USD10,790,000USD7,391,000USD5,937,000USD6,889,000USD9,227,000USD
    Short Long Term Debt Total—40,903,000USD40,977,000USD42,212,000USD31,774,000USD32,305,000USD34,271,000USD38,153,000USD
    Short Term Investments—199,372,000USD180,222,000USD129,788,999USD377,885,000USD347,742,000USD384,281,000USD371,537,000USD
    Inventory—87,062,000USD82,385,000USD79,399,000USD44,023,000USD49,423,000USD54,293,000USD63,981,000USD
    Property Plant Equipment Gross—28,795,000USD28,795,000USD30,087,000USD30,048,000USD29,778,000USD29,388,000USD29,117,000USD
    Common Stock Shares Outstanding—57,647,548shares57,344,000shares56,552,741shares56,643,189shares55,864,692shares56,464,768shares56,016,350shares
    Non Current Assets Total—769,144,999USD808,466,000USD825,863,000USD643,539,000USD659,706,000USD682,003,000USD702,698,000USD
    Non Current Liabilities Total—49,991,000USD52,763,000USD39,458,000USD32,145,000USD34,813,000USD39,943,000USD44,043,000USD
    Non Current Liabilities Other—19,724,000USD22,398,000USD8,036,000USD7,762,000USD7,464,000USD7,600,000USD7,753,000USD
    Non Currrent Assets Other—30,055,999USD65,246,000USD72,675,000USD27,963,000USD29,223,000USD31,527,000USD33,647,000USD
    Net Working Capital—357,651,000USD306,011,000USD263,262,000USD452,506,000USD405,812,000USD393,673,000USD348,495,000USD
    Unclassified Non Current Assets—32,269,999USD38,351,000USD—————
    Unclassified Non Current Liabilities—30,267,000USD30,365,000USD31,422,000USD24,383,000USD27,349,000USD32,343,000USD36,290,000USD
    Unclassified Equity—561,361,001USD543,768,000USD527,642,999USD496,890,000USD486,153,000USD479,384,000USD465,864,000USD
    Long Term Investments——————0USD0USD
    Current Deferred Revenue———————-15,619,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets1,452,648,000USD1,368,073,000USD1,277,673,000USD1,702,508,000USD1,689,152,000USD1,504,102,000USD1,160,282,000USD977,811,000USD
    Intangible Assets569,456,000USD521,912,000USD599,889,000USD702,463,000USD784,693,000USD364,342,000USD24,840,000USD31,368,000USD
    Other Current Assets65,325,000USD36,088,000USD16,676,000USD15,779,000USD27,019,000USD18,682,000USD11,611,000USD8,888,000USD
    Total Liab390,934,000USD332,340,000USD356,157,000USD816,304,000USD873,301,000USD759,244,000USD564,854,000USD524,788,000USD
    Total Stockholder Equity1,061,714,000USD1,035,733,000USD921,516,000USD886,204,000USD815,851,000USD744,858,000USD595,428,000USD453,023,000USD
    Other Current Liab324,882,000USD280,921,000USD279,901,000USD268,656,000USD299,571,000USD235,201,000USD145,178,000USD158,158,000USD
    Common Stock57,000USD56,000USD55,000USD54,000USD53,000USD53,000USD53,000USD52,000USD
    Capital Stock57,000USD56,000USD55,000USD54,000USD53,000USD53,000USD53,000USD52,000USD
    Retained Earnings517,876,000USD556,426,000USD482,561,000USD481,245,000USD379,922,000USD326,498,000USD199,548,000USD86,492,000USD
    Good Will124,882,000USD117,019,000USD117,019,000USD117,019,000USD117,516,000USD77,911,000USD24,840,000USD31,368,000USD
    Cash128,448,000USD69,331,000USD75,054,000USD93,120,000USD203,434,000USD288,640,000USD181,381,000USD192,248,000USD
    Cash And Short Term Investments308,670,000USD453,612,000USD254,874,000USD461,334,000USD339,680,000USD422,533,000USD347,073,000USD356,018,000USD
    Total Current Assets644,182,000USD686,070,000USD493,113,000USD734,151,000USD601,590,000USD630,417,000USD472,644,000USD493,487,000USD
    Total Current Liabilities338,171,000USD292,397,000USD290,196,000USD687,958,000USD315,379,000USD245,108,000USD160,587,000USD161,353,000USD
    Net Debt-87,471,000USD-35,060,000USD-33,527,000USD351,637,000USD223,593,000USD125,685,000USD197,054,000USD137,214,000USD
    Short Term Debt10,612,000USD6,889,000USD8,331,000USD408,759,000USD6,477,000USD3,760,000USD2,825,000USD2,183,000USD
    Short Long Term Debt Total40,977,000USD34,271,000USD41,527,000USD444,757,000USD427,027,000USD414,325,000USD378,435,000USD331,645,000USD
    Short Term Investments180,222,000USD384,281,000USD179,820,000USD368,214,000USD136,246,000USD133,893,000USD165,692,000USD163,770,000USD
    Net Receivables187,802,000USD142,077,000USD144,155,000USD165,497,000USD148,932,000USD140,877,000USD87,332,000USD102,922,000USD
    Inventory82,385,000USD54,293,000USD77,408,000USD91,541,000USD85,959,000USD48,325,000USD26,628,000USD25,659,000USD
    Accounts Payable2,677,000USD4,587,000USD1,964,000USD10,543,000USD9,331,000USD6,147,000USD10,141,000USD3,195,000USD
    Property Plant Equipment Net10,531,000USD11,545,000USD13,530,000USD15,173,000USD16,955,000USD37,824,000USD17,068,000USD4,095,000USD
    Property Plant Equipment Gross28,795,000USD29,388,000USD28,935,000USD28,222,000USD33,409,000USD37,824,000USD38,347,000USD4,095,000USD
    Accumulated Other Comprehensive Income-44,000USD-189,000USD-593,000USD-3,210,000USD1,539,000USD8,975,000USD7,417,000USD-3,158,000USD
    Common Stock Shares Outstanding56,451,136shares55,959,000shares55,506,828shares61,679,800shares54,356,744shares53,689,743shares53,816,754shares54,098,872shares
    Non Current Assets Total808,466,000USD682,003,000USD784,560,000USD968,357,000USD1,087,562,000USD873,685,000USD687,638,000USD484,324,000USD
    Non Current Liabilities Total52,763,000USD39,943,000USD65,961,000USD128,346,000USD557,922,000USD514,136,000USD404,267,000USD363,435,000USD
    Non Current Liabilities Other22,398,000USD7,600,000USD7,802,000USD42,539,000USD35,637,000USD45,800,000USD59,097,000USD33,973,000USD
    Non Currrent Assets Other65,246,000USD31,527,000USD37,505,000USD39,806,000USD49,232,000USD43,249,000USD21,894,000USD380,000USD
    Net Working Capital306,011,000USD393,673,000USD202,917,000USD46,193,000USD286,211,000USD385,309,000USD312,057,000USD332,134,000USD
    Unclassified Non Current Assets38,351,000USD——-10,902,000USD-13,867,000USD-259,715,000USD-25,455,000USD-31,748,000USD
    Unclassified Non Current Liabilities30,365,000USD32,343,000USD58,159,000USD-56,350,000USD-79,694,000USD-52,436,000USD-28,657,000USD-33,973,000USD
    Unclassified Equity543,768,000USD479,384,000USD439,438,000USD408,061,000USD434,284,000USD409,279,000USD388,357,000USD369,585,000USD
    Long Term Investments—0USD16,617,000USD93,896,000USD119,166,000USD350,359,000USD591,773,000USD418,798,000USD
    Current Deferred Revenue——1USD49,809,000USD126,247,000USD122,432,000USD144,377,000USD-2,183,000USD
    Deferred Long Term Liab———49,809,000USD85,355,000USD35,215,000USD——
    Other Liab———92,348,000USD137,372,000USD123,806,000USD28,657,000USD33,973,000USD
    Other Assets———10,902,000USD13,867,000USD259,715,000USD32,678,000USD30,063,000USD
    Short Long Term Debt———401,968,000USD————
    Net Tangible Assets———66,722,000USD-86,358,000USD302,605,000USD570,588,000USD421,655,000USD
    Unclassified Current Liabilities———-451,777,000USD-126,247,000USD-122,432,000USD-141,934,000USD-2,183,000USD
    Long Term Debt————379,252,000USD361,751,000USD345,170,000USD329,462,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Net Income-2,293,000USD-45,117,000USD22,499,000USD-11,827,000USD15,328,000USD38,497,000USD19,916,000USD124,000USD
    Depreciation25,940,000USD24,806,000USD21,358,000USD20,383,000USD18,845,000USD20,088,000USD20,718,000USD20,749,000USD
    Stock Based Compensation8,480,000USD7,825,000USD7,507,000USD8,068,000USD7,632,000USD7,674,000USD6,552,000USD5,897,000USD
    Other Non Cash Items6,727,000USD2,667,000USD2,841,000USD4,059,000USD7,802,000USD1,613,000USD-544,000USD3,248,000USD
    Change To Account Receivables5,619,000USD-7,131,000USD4,809,000USD-3,563,000USD3,331,000USD7,086,000USD-4,760,000USD-3,579,000USD
    Change To Inventory-105,000USD-12,940,000USD4,887,000USD4,731,000USD3,187,000USD4,604,000USD6,025,000USD1,990,000USD
    Change In Working Capital21,754,000USD-49,200,000USD11,492,000USD13,906,000USD-5,129,000USD-7,885,000USD-2,903,000USD13,865,000USD
    Total Cash From Operating Activities66,524,000USD-61,664,000USD58,535,000USD30,599,000USD44,406,000USD53,520,000USD35,624,000USD38,401,000USD
    Capital Expenditures0USD-129,000USD-455,000USD-327,000USD-213,000USD-200,000USD-64,000USD-248,000USD
    Free Cash Flow66,524,000USD-61,793,000USD58,080,000USD30,272,000USD44,193,000USD53,320,000USD35,560,000USD38,153,000USD
    Investments-19,218,000USD48,706,000USD-30,607,000USD37,317,000USD-12,638,000USD-77,011,000USD-48,594,000USD-51,624,000USD
    Total Cashflows From Investing Activities-19,218,000USD48,706,000USD-30,607,000USD37,317,000USD-12,638,000USD-77,011,000USD-48,594,000USD-51,624,000USD
    Total Cash From Financing Activities9,115,000USD21,068,000USD935,000USD-21,399,000USD5,890,000USD3,075,000USD1,658,000USD1,570,000USD
    Issuance Of Capital Stock13,670,000USD23,741,000USD3,276,000USD2,042,000USD6,877,000USD3,462,000USD1,659,000USD2,910,000USD
    Change In Cash56,421,000USD8,110,000USD28,863,000USD46,517,000USD37,658,000USD-20,416,000USD-11,312,000USD-11,653,000USD
    Begin Period Cash Flow129,898,000USD144,711,000USD115,848,000USD69,331,000USD31,673,000USD52,089,000USD63,401,000USD75,054,000USD
    End Period Cash Flow186,319,000USD152,821,000USD144,711,000USD115,848,000USD69,331,000USD31,673,000USD52,089,000USD63,401,000USD
    Other Cashflows From Investing Activities21,000USD-293,093,000USD———9,000USD-48,530,000USD-51,376,000USD
    Other Cashflows From Financing Activities-4,555,000USD-2,673,000USD-2,341,000USD-23,441,000USD-987,000USD-387,000USD-1,000USD-1,340,000USD
    Unclassified Operating Cash Flow5,916,000USD-2,645,000USD-7,162,000USD-3,990,000USD—-6,467,000USD-8,115,000USD-5,482,000USD
    Unclassified Investing Cash Flow—293,222,000USD————48,594,000USD51,624,000USD
    Net Borrowings————0USD0USD——
    Sale Purchase Of Stock—————1,341,000USD-1,000USD-1,340,000USD
    Unclassified Financing Cash Flow—————2,121,000USD1,660,000USD4,250,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-38,550,000USD73,865,000USD1,316,000USD60,711,000USD53,424,000USD126,950,000USD113,056,000USD110,993,000USD
    Depreciation90,034,000USD80,414,000USD84,859,000USD85,543,000USD32,595,000USD18,141,000USD6,659,000USD7,063,000USD
    Stock Based Compensation33,051,000USD27,755,000USD26,759,000USD17,568,000USD17,910,000USD16,561,000USD14,846,000USD11,291,000USD
    Other Non Cash Items32,749,000USD12,105,000USD33,002,000USD3,571,000USD24,622,000USD12,694,000USD13,787,000USD8,540,000USD
    Change To Account Receivables-22,304,000USD2,078,000USD18,765,000USD-16,366,000USD3,867,000USD-34,607,000USD15,751,000USD-35,856,000USD
    Change To Inventory-7,502,000USD15,806,000USD6,110,000USD-17,858,000USD-14,580,000USD-10,124,000USD-969,000USD-9,355,000USD
    Change In Working Capital-75,159,000USD-2,052,000USD-9,137,000USD-24,243,000USD3,570,000USD-36,515,000USD613,000USD-4,734,000USD
    Total Cash From Operating Activities47,331,000USD171,951,000USD111,085,000USD116,826,000USD127,127,000USD138,399,000USD143,129,000USD128,986,000USD
    Capital Expenditures-1,338,000USD-725,000USD-551,000USD-412,000USD-2,045,000USD-3,449,000USD-2,736,000USD-844,000USD
    Free Cash Flow45,993,000USD171,226,000USD110,534,000USD116,414,000USD125,082,000USD134,950,000USD140,393,000USD128,142,000USD
    Investments298,537,000USD-189,867,000USD285,945,000USD-216,251,000USD218,936,000USD267,532,000USD-156,537,000USD-411,827,000USD
    Total Cashflows From Investing Activities4,106,000USD-189,867,000USD268,729,000USD-216,663,000USD-81,913,000USD-34,699,000USD-157,924,000USD-413,480,000USD
    Net Borrowings0USD0USD-402,500,000USD0USD-138,315,000USD-802,000USD-802,000USD392,065,000USD
    Total Cash From Financing Activities9,130,000USD12,193,000USD-397,880,000USD-10,477,000USD-130,420,000USD3,559,000USD3,928,000USD376,438,000USD
    Issuance Of Capital Stock37,616,000USD14,908,000USD6,357,000USD12,423,000USD7,095,000USD4,361,000USD3,928,000USD11,582,000USD
    Change In Cash60,567,000USD-5,723,000USD-18,066,000USD-110,314,000USD-85,206,000USD107,259,000USD-10,867,000USD91,944,000USD
    Begin Period Cash Flow69,331,000USD75,054,000USD93,120,000USD203,434,000USD288,640,000USD181,381,000USD192,248,000USD100,304,000USD
    End Period Cash Flow129,898,000USD69,331,000USD75,054,000USD93,120,000USD203,434,000USD288,640,000USD181,381,000USD192,248,000USD
    Other Cashflows From Investing Activities-439,000USD9,000USD—14,000USD12,888,000USD-241,000USD1,349,000USD-809,000USD
    Other Cashflows From Financing Activities-28,486,000USD-2,715,000USD-1,990,000USD-22,900,000USD-81,913,000USD-34,699,000USD3,928,000USD55,253,000USD
    Unclassified Operating Cash Flow5,206,000USD-20,136,000USD-25,714,000USD-26,324,000USD-4,994,000USD—-5,832,000USD-4,167,000USD
    Unclassified Investing Cash Flow-292,654,000USD—-16,665,000USD—-311,692,000USD-298,541,000USD——
    Sale Purchase Of Stock——-1,990,000USD12,423,000USD7,095,000USD4,361,000USD3,928,000USD77,270,000USD
    Unclassified Financing Cash Flow——8,600,000USD—82,713,000USD34,699,000USD-3,126,000USD-148,150,000USD
    Change To Liabilities———-19,163,000USD18,179,000USD8,272,000USD-11,871,000USD4,124,000USD
    Cash And Cash Equivalents Changes———-110,314,000USD-85,206,000USD107,259,000USD-10,867,000USD91,944,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductAPOKYN6,323,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductCollaboration Revenue35,350,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductGOCOVRI37,530,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductManufactured Product Other1,882,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductONAPGO13,546,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductOxtellar XR8,782,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductQelbree89,239,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductRoyalty License And Other Revenue17,995,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductTrokendi Xr8,411,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductAPOKYN7,728,000USD0001356576-26-000022
    Q1 2026Quarterly · 2026-03-31ProductCollaboration Revenue27,643,000USD0001356576-26-000022
    Q1 2026Quarterly · 2026-03-31ProductGOCOVRI35,240,000USD0001356576-26-000022
    Q1 2026Quarterly · 2026-03-31ProductManufactured Product Other4,666,000USD0001356576-26-000022
    Q1 2026Quarterly · 2026-03-31ProductONAPGO8,375,000USD0001356576-26-000022
    Q1 2026Quarterly · 2026-03-31ProductOxtellar XR7,422,000USD0001356576-26-000022
    Q1 2026Quarterly · 2026-03-31ProductQelbree77,843,000USD0001356576-26-000022
    Q1 2026Quarterly · 2026-03-31ProductRoyalty License And Other Revenue29,309,000USD0001356576-26-000022
    Q1 2026Quarterly · 2026-03-31ProductTrokendi Xr9,479,000USD0001356576-26-000022
    FY 2025Yearly · 2025-12-31ProductAPOKYN47,771,000USD0001356576-26-000011
    FY 2025Yearly · 2025-12-31ProductCollaboration Revenue52,996,000USD0001356576-26-000011
    FY 2025Yearly · 2025-12-31ProductGOCOVRI146,824,000USD0001356576-26-000011
    FY 2025Yearly · 2025-12-31ProductManufactured Product Other26,912,000USD0001356576-26-000011
    FY 2025Yearly · 2025-12-31ProductONAPGO17,254,000USD0001356576-26-000011
    FY 2025Yearly · 2025-12-31ProductOxtellar XR40,700,000USD0001356576-26-000011
    FY 2025Yearly · 2025-12-31ProductQelbree304,654,000USD0001356576-26-000011
    FY 2025Yearly · 2025-12-31ProductRoyalty License And Other Revenue39,420,000USD0001356576-26-000011
    FY 2025Yearly · 2025-12-31ProductTrokendi Xr42,421,000USD0001356576-26-000011
    Q3 2025Quarterly · 2025-09-30ProductAPOKYN10,387,000USD0001356576-25-000071
    Q3 2025Quarterly · 2025-09-30ProductCollaboration Revenue20,164,000USD0001356576-25-000071
    Q3 2025Quarterly · 2025-09-30ProductGOCOVRI40,849,000USD0001356576-25-000071
    Q3 2025Quarterly · 2025-09-30ProductManufactured Product Other7,025,000USD0001356576-25-000071
    Q3 2025Quarterly · 2025-09-30ProductONAPGO6,806,000USD0001356576-25-000071
    Q3 2025Quarterly · 2025-09-30ProductOxtellar XR12,016,000USD0001356576-25-000071
    Q3 2025Quarterly · 2025-09-30ProductQelbree81,416,000USD0001356576-25-000071
    Q3 2025Quarterly · 2025-09-30ProductRoyalty License And Other Revenue3,397,000USD0001356576-25-000071
    Q3 2025Quarterly · 2025-09-30ProductTrokendi Xr10,043,000USD0001356576-25-000071
    Q2 2025Quarterly · 2025-06-30ProductAPOKYN12,820,000USD0001356576-25-000055
    Q2 2025Quarterly · 2025-06-30ProductGOCOVRI36,660,000USD0001356576-25-000055
    Q2 2025Quarterly · 2025-06-30ProductManufactured Product Other6,534,000USD0001356576-25-000055
    Q2 2025Quarterly · 2025-06-30ProductONAPGO1,604,000USD0001356576-25-000055
    Q2 2025Quarterly · 2025-06-30ProductOxtellar XR11,637,000USD0001356576-25-000055
    Q2 2025Quarterly · 2025-06-30ProductQelbree77,547,000USD0001356576-25-000055
    Q2 2025Quarterly · 2025-06-30ProductRoyalty License And Other Revenue7,458,000USD0001356576-25-000055
    Q2 2025Quarterly · 2025-06-30ProductTrokendi Xr11,193,000USD0001356576-25-000055
    Q1 2025Quarterly · 2025-03-31ProductAPOKYN14,976,000USD0001356576-26-000022
    Q1 2025Quarterly · 2025-03-31ProductCollaboration Revenue0USD0001356576-26-000022
    Q1 2025Quarterly · 2025-03-31ProductGOCOVRI30,689,000USD0001356576-26-000022
    Q1 2025Quarterly · 2025-03-31ProductManufactured Product Other8,579,000USD0001356576-26-000022
    Q1 2025Quarterly · 2025-03-31ProductONAPGO0USD0001356576-26-000022
    Q1 2025Quarterly · 2025-03-31ProductOxtellar XR10,198,000USD0001356576-26-000022
    Q1 2025Quarterly · 2025-03-31ProductQelbree64,745,000USD0001356576-26-000022
    Q1 2025Quarterly · 2025-03-31ProductRoyalty License And Other Revenue7,836,000USD0001356576-26-000022
    Q1 2025Quarterly · 2025-03-31ProductTrokendi Xr12,801,000USD0001356576-26-000022
    Q4 2024Quarterly · 2024-12-31ProductAPOKYN20,115,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductGOCOVRI36,902,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductManufactured Product Other6,955,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductOxtellar XR13,200,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductQelbree74,415,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductRoyalty License And Other Revenue7,764,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductTrokendi Xr14,808,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductAPOKYN73,926,000USD0001356576-26-000011
    FY 2024Yearly · 2024-12-31ProductCollaboration Revenue0USD0001356576-26-000011
    FY 2024Yearly · 2024-12-31ProductGOCOVRI130,824,000USD0001356576-26-000011
    FY 2024Yearly · 2024-12-31ProductManufactured Product Other29,008,000USD0001356576-26-000011
    FY 2024Yearly · 2024-12-31ProductONAPGO0USD0001356576-26-000011
    FY 2024Yearly · 2024-12-31ProductOxtellar XR99,464,000USD0001356576-26-000011
    FY 2024Yearly · 2024-12-31ProductQelbree241,273,000USD0001356576-26-000011
    FY 2024Yearly · 2024-12-31ProductRoyalty License And Other Revenue24,121,000USD0001356576-26-000011
    FY 2024Yearly · 2024-12-31ProductTrokendi Xr63,201,000USD0001356576-26-000011
    Q3 2024Quarterly · 2024-09-30ProductAPOKYN19,867,000USD0001356576-25-000071
    Q3 2024Quarterly · 2024-09-30ProductCollaboration Revenue0USD0001356576-25-000071
    Q3 2024Quarterly · 2024-09-30ProductGOCOVRI35,657,000USD0001356576-25-000071
    Q3 2024Quarterly · 2024-09-30ProductManufactured Product Other7,296,000USD0001356576-25-000071
    Q3 2024Quarterly · 2024-09-30ProductONAPGO0USD0001356576-25-000071
    Q3 2024Quarterly · 2024-09-30ProductOxtellar XR29,805,000USD0001356576-25-000071
    Q3 2024Quarterly · 2024-09-30ProductQelbree62,359,000USD0001356576-25-000071
    Q3 2024Quarterly · 2024-09-30ProductRoyalty License And Other Revenue5,387,000USD0001356576-25-000071
    Q3 2024Quarterly · 2024-09-30ProductTrokendi Xr15,318,000USD0001356576-25-000071
    Q2 2024Quarterly · 2024-06-30ProductAPOKYN17,295,000USD0001356576-25-000055
    Q2 2024Quarterly · 2024-06-30ProductGOCOVRI31,703,000USD0001356576-25-000055
    Q2 2024Quarterly · 2024-06-30ProductManufactured Product Other7,543,000USD0001356576-25-000055
    Q2 2024Quarterly · 2024-06-30ProductONAPGO0USD0001356576-25-000055
    Q2 2024Quarterly · 2024-06-30ProductOxtellar XR29,516,000USD0001356576-25-000055
    Q2 2024Quarterly · 2024-06-30ProductQelbree59,395,000USD0001356576-25-000055
    Q2 2024Quarterly · 2024-06-30ProductRoyalty License And Other Revenue5,787,000USD0001356576-25-000055
    Q2 2024Quarterly · 2024-06-30ProductTrokendi Xr17,086,000USD0001356576-25-000055
    FY 2023Yearly · 2023-12-31ProductAPOKYN75,083,000USD0001356576-26-000011
    FY 2023Yearly · 2023-12-31ProductCollaboration Revenue0USD0001356576-26-000011
    FY 2023Yearly · 2023-12-31ProductGOCOVRI119,637,000USD0001356576-26-000011
    FY 2023Yearly · 2023-12-31ProductManufactured Product Other31,281,000USD0001356576-26-000011
    FY 2023Yearly · 2023-12-31ProductONAPGO0USD0001356576-26-000011
    FY 2023Yearly · 2023-12-31ProductOxtellar XR113,404,000USD0001356576-26-000011
    FY 2023Yearly · 2023-12-31ProductQelbree140,192,000USD0001356576-26-000011
    FY 2023Yearly · 2023-12-31ProductRoyalty License And Other Revenue33,588,000USD0001356576-26-000011
    FY 2023Yearly · 2023-12-31ProductTrokendi Xr94,336,000USD0001356576-26-000011
    FY 2022Yearly · 2022-12-31ProductAPOKYN75,305,000USD0001356576-25-000017
    FY 2022Yearly · 2022-12-31ProductGOCOVRI104,421,000USD0001356576-25-000017
    FY 2022Yearly · 2022-12-31ProductManufactured Product Other31,818,000USD0001356576-25-000017
    FY 2022Yearly · 2022-12-31ProductOxtellar XR115,345,000USD0001356576-25-000017
    FY 2022Yearly · 2022-12-31ProductQelbree61,322,000USD0001356576-25-000017

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.